In My Words Podcast

The In My Words podcast series brings together the experiences of real patients with the clinical thought of health care professionals directly to listeners to create an engaging educational experience. Learning how to manage your life after a diagnosis can be stressful and confusing, and the aim of these podcasts is to empower listeners to own their health. Jumo Health, in collaboration with Diabetes New Zealand and Sanofi has produced a two mini podcast series on type I and type II diabetes as a part of their 'In My Words' podcast series.

Trudy, Daron and Karl discuss a variety of topics such as the impact diabetes has on their lives, disease management, how they try to live a healthy lifestyle managing their diabetes and relationship management. Daron and Karl’s episodes also feature Joanna Naylor, a diabetes nurse and Dr. Rinki Murphy, a diabetes specialist who works at Auckland District Health Board and Manukau SuperClinic™. They are both involved in caring for patients with diabetes and talk about the condition from the clinical perspective.

Available on the following:

About Jumo Health

Jumo Health develops age appropriate, educational resources for patients and their care circle for use throughout their medical journey.

By working with providers, manufacturers, and advocacy groups, we ensure our resources are available at the moment of diagnosis, during a treatment regimen, or while participating in a clinical trial. With the belief that an informed patient is a compliant patient, Jumo Health designs practical solutions using popular mediums. With experience providing resources to more than 70 countries in 80 languages, covering more than 200 topics, our mixed media solutions range from comic books to animated videos, are evidence based and peer reviewed, and pay careful attention to health literacy and reading comprehension barriers.

‍Find more resources at JumoHealth.com.

Jumo Health: 110 East 42nd Street, 8th Floor, New York, New York 10017.

Supported by Diabetes NZ, sponsored by Sanofi:

MAT-NZ-2100010. Date of preparation March 2021. TAPS PP7426.